cholestasis/carbohydrate

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 107 rezilta yo

Intestinal capacity to digest and absorb carbohydrates is maintained in a rat model of cholestasis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Cholestasis is associated with systemic accumulation of bile salts and with deficiency of bile in the intestinal lumen. During the past years bile salts have been identified as signaling molecules that regulate lipid, glucose, and energy metabolism. Bile salts have also been shown to activate

[Carbohydrate metabolism during cholestasis in pregnancy].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Blood glucose levels were measured in fasting state and 2 hours after breakfast, together with glucose tolerance tests (after a load of 100 g of glucose) and 24-hour glycaemia profile in pregnant women with intrahepatic cholestasis of pregnancy in the third trimester of pregnancy. In all these tests

Carbohydrate metabolism in the course of intrahepatic cholestasis in pregnancy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Glucose metabolism was evaluated in pregnant women with clinically and biochemically demonstrated intrahepatic cholestasis. Laboratory investigations included measurements of serum glucose concentrations on fasting and 2 hours after breakfast, the glucose tolerance test (100 gm oral glucose load),

Changes in the acinar distribution of some enzymes involved in carbohydrate metabolism in rat liver parenchyma after experimentally induced cholestasis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Extrahepatic cholestasis induced by ligation and transsection of the common bile duct caused a change in the parenchyma/stroma relationship in rat liver. Two weeks after ligation, the periportal zones of the parenchyma were progressively invaded by expanding bile ductules with surrounding connective

Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Stearoyl-coenzyme A desaturase 1-deficient (SCD1(-/-)) mice have impaired MUFA synthesis. When maintained on a very low-fat (VLF) diet, SCD1(-/-) mice developed severe hypercholesterolemia, characterized by an increase in apolipoprotein B (apoB)-containing lipoproteins and the appearance of

[ANIT cholestasis in the rat liver: effect of glucocorticoid administration on the metabolites of carbohydrate metabolism].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

[Role of carbohydrates in the development of cholestasis during total parenteral feeding].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Do patients with lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Patients with lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholestatic. We wanted to assess the need for dietary counselling outside cholestatic episodes, and hypothetized that no counselling was needed. METHODS Fifteen patients above 10 years of age

Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Carbohydrate antigen 19-9 (CA 19-9) is the serum marker used to diagnose cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis (PSC). OBJECTIVE We investigated long-term outcomes in patients with PSC and elevated CA 19-9 levels without CCA. METHODS A total of 166 PSC

Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Biological markers for chronic alcohol consumption like MCV or gammaGT or carbohydrate deficient transferrin (CDT) are useful, but far from being perfect. In patients with liver disease a reliable marker for chronic alcohol consumption as the underlying etiology is highly needed.

Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Parenteral nutrition-associated cholestasis (PNAC) is a complication of long-term parenteral nutrition (PN). Removal of lipids may reverse PNAC but compromises the energy to ensure infant growth. The purpose of this study was to test whether a low-fat, high-carbohydrate PN regimen, which

Study of the tumor marker carbohydrate antigen 50 in liver cirrhosis. Pathogenetic considerations.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Carbohydrate antigen 50 (CA 50) is a tumor marker that increases in many malignancies, especially in carcinoma of the digestive tract. False-positive results occur in benign liver disease. The behavior of CA 50 in 86 cirrhotic patients was studied, with thorough clinical and laboratory evaluations.

Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Few cases of infantile liver disease associated with mitochondrial DNA (mtDNA) depletion have been reported. Most of the patients died before 1 year of age of severe liver failure. We describe a new case, a 28-month-old child, presenting with cholestasis at age 2 months, complicated by progressive

Serum level of biliary glycoprotein I, a determinant of cholestasis, of similar use as gamma-glutamyltranspeptidase.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Biliary glycoprotein I (BGP I), a constituent of normal bile and serum, is a glycoprotein (mol. wt. approximately 90,000) containing about 40% carbohydrate. Serum BGP I (S-BGP I) was determined by means of a double-antibody radioimmunoassay in patients with liver and gastrointestinal disease and in

The efficacy of the combination of percutaneous transhepatic biliary drainage and ¹²⁵ I stranded seeds for malignant bile duct obstruction treatment

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Purpose: To investigate the efficacy of percutaneous transhepatic biliary drainage (PTBD) combined with iodine-125 (¹²⁵I) stranded seeds for the treatment of malignant bile duct obstruction (MBO).

Previous
1
2
3
4
5
6
7
8
Next

Antre nan paj
facebook nou an
Herbal & Natural Medicine
Baz done ki pi konplè remèd fèy medsin te apiye nan syans
Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive
Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

cholestasis/carbohydrate

Intestinal capacity to digest and absorb carbohydrates is maintained in a rat model of cholestasis.

[Carbohydrate metabolism during cholestasis in pregnancy].

Carbohydrate metabolism in the course of intrahepatic cholestasis in pregnancy.

Changes in the acinar distribution of some enzymes involved in carbohydrate metabolism in rat liver parenchyma after experimentally induced cholestasis.

Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet.

[ANIT cholestasis in the rat liver: effect of glucocorticoid administration on the metabolites of carbohydrate metabolism].

[Role of carbohydrates in the development of cholestasis during total parenteral feeding].

Do patients with lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes?

Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma.

Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?

Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants.

Study of the tumor marker carbohydrate antigen 50 in liver cirrhosis. Pathogenetic considerations.

Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis.

Serum level of biliary glycoprotein I, a determinant of cholestasis, of similar use as gamma-glutamyltranspeptidase.

The efficacy of the combination of percutaneous transhepatic biliary drainage and 125 I stranded seeds for malignant bile duct obstruction treatment

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

The efficacy of the combination of percutaneous transhepatic biliary drainage and ¹²⁵ I stranded seeds for malignant bile duct obstruction treatment